Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis and Treatment of Sleep Disordered Breathing in Lung Cancer

NCT03443908 is registered in ClinicalTrials.gov with Mark M. Fuster, MD as lead sponsor.

NCT NCT03443908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03443908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis and Treatment of Sleep Disordered Breathing in Lung Cancer
Lead sponsor
Mark M. Fuster, MD
Phase
Observational
Overall status
Withdrawn
Start date
November 17, 2017
Completion date
May 13, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer